ds-oligonucleotide-peptide conjugates featuring peptides from the leucine-zipper region of Fos as switchable receptors for the oncoprotein Jun

ChemBioChem

Volumn 8, Issue 10, 2007, Pages 1110-1114

  Portela, Cecilia ^a   Albericio, Fernando ^b   Eritja, Ramón ^c   Castedo, Luis ^a   Mascareñas, José L ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

Conjugation; Fos Jun; Molecular recognition; Oligonucleotides; Peptides; Transcription factors

Indexed keywords

LEUCINE ZIPPER PROTEIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTEIN FOS; TRANSCRIPTION FACTOR;

ARTICLE; DNA BINDING; PRIORITY JOURNAL; RNA INTERFERENCE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; DNA, SINGLE-STRANDED; HUMANS; LEUCINE ZIPPERS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OLIGONUCLEOTIDES; ONCOGENE PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 34547575681     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200700115     Document Type: Article

References (42)

1. See, for example: a) D. A. Stetsenko, A. A. Arzumanov, V. A. Korshun, M. A. Gait, Mol. Biol. (Moscow) 2000, 34, 852-859;
2. b) A. Austriab-Fisher, D. S. Sergueev, M. Fisher, B. S. Ramsay, R. Juliano, Biochem. Pharmacol. 2000, 60, 83-90;
3. c) M. J. Gait, Cell. Mol. Life Sci. 2003, 60, 1-10;
4. T. Nagasaki, T. Myohoji, T. Tachibana, S. Futaki, S. Tamagaki, Bioconjugate Chem. 2003, 14, 282-286.
5. a) C. H. Tung, S. Stein, Bioconjugate Chem. 2000, 11, 605-618;
6. b) S. T. Crooke, Annu. Rev. Med. 2004, 55, 61-95.
7. For a recent comprehensive review, see: N. Venkatesan, B. H. Kim, Chem. Rev. 2006, 106, 3712-3761.
8. a) R. Eritja, Solid-Phase Synthesis, A Practical Guide (Eds.: S. A. Kates, F. Albericio), Marcel Dekker, New York, 2000, pp. 529-548;
9. b) E. M. Zubin, E. A. Romanova, T. S. Oretskaya, Russ. Chem. Rev. 2002, 71, 239-264;
10. c) C. P. Chen, J. M. Min, L. H. Zhang, Prog. Biochem. Biophys. 2001, 28, 783-787;
11. d) A. Grandas, V. Marchán, L. Debéthune, E. Pedroso, Curr. Protoc. Nucleic Acid Chem. 2004, unit 4.22.
12. a) D. A. Stetsenko, M. A. Gait, Org. Lett. 2002, 4, 3259-3262;
13. b) S. M. Ocampo, F. Albericio, I. Fernández, M. Vilaseca, R. Eritja, Org. Lett. 2005, 7, 4349-4352.
14. a) Y. Singh, E. Defranc, P. Dumy, J. Org. Chem. 2004, 69, 8544-8546;
15. b) F. A. Rogers, M. Manoharan, P. Rabinovitch, D. C. Ward, P. M. Glazer, Nucleic Acids Res. 2004, 32, 6595-6604.
16. Many transcription factors bind specific DNA sequences as noncovalent homo- or hetero-oligomers, for reviews see: a) R. J. White, Gene Transcription, Mechanism and Control, Blackwell, Oxford, 2001;
17. b) D. S. Latchman, Transcriptional Factors: Structural Families and Principles of DNA Recognition, Academic Press, San Diego, 1998;
18. c) C. O. Pabo, R. T. Sauer, Annu. Rev. Biochem. 1992, 61, 1053-1095;
19. d) S. K. Burley, Curr. Opin. Struct. Biol. 1994, 4, 3-11;
20. e) C. W. Garvie, C. Wolberger, Mol. Cell 2001, 8, 936-946;
21. f) J. T. Kadonaga, Cell 2004, 116, 247-257.
22. a) P. K. Vogt, Oncogene 2001, 20, 2365-2377;
23. b) E. Shaulian, M. Karin, Nat. Cell. Biol. 2002, 4, E131-E136.
24. The proto-oncoproteins of the Fos and Jun families are prominent members of the basic-leucine zipper (bZIP) DNA-binding family of proteins: a) Y. Chinenov, T. K. Kerppola, Oncogene 2001, 20, 2438-2452;
25. b) J. N. M. Glover, S. C Harrison, Nature 1995, 373, 257-261.
26. a) S. Yao, M. Brickner, E. I. Pares-Matos, J. Chmielewski, Biopolymers 1998, 47, 277-283;
27. Recombinant proteins containing a 30-amino-acid acidic extension at the N terminus of the Fos leucine zipper have been shown to be efficient inhibitors of AP-1 DNA binding. b) M. Olive, D. Krylov, D. R. Echlin, K. Gardner, E. Taparowsky, C. Vinson, J. Biol. Chem. 1997, 272, 18586-18594.
28. D. Gottschling, H. Seliger, G. Tarrasón, J. Piulats, R. Eritja, Bioconjugate Chem. 1998, 9, 831.
29. For the synthesis of 3b, two additional equivalents of thiol-oligonucleotide 1 were added portionwise in order to ensure total consumption of peptide 2b, since the HPLC retention times of 2b and 3b are similar.
30. The synthesis of an oligonucleotide-peptide phosphorothioate conjugate incorporating a peptide with 26 amino acids has been reported: M. Antopolsky, U. Tengvall, S. Auriola, I. Jääskeläinen, S. Rönkkö, P. Honkakoshi, A. Urtti, H. Lönnberg, A. Azhayev, Bioconjugate Chem. 1999, 10, 598-606.
31. The conjugation between a hairpin oligonucleotide and dodecapeptide has been reported: M. A. Zanta, P. Belguise-Valladier, J. P. Behr, Proc. Natl. Acad. Sci. USA 1999, 96, 91-96.
32. See also: D. Stanojevic, G. L. Verdine, Nat. Struct. Biol. 1995, 450-457.
33. The sample of c-Jun used for the assays was obtained by recombinant methods and consists of the following sequence (amino acids 262-324): MKAERKRMRNRIAASKSRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNH.
34. This dsDNA-peptide derivative was obtained by annealing the oligonucleotide-peptide hybrid 4 with its complementary strand, with 4 being identical to 3b but featuring a different DNA sequence: 5′-GTACGTCTGCATT-3′. This hybrid was prepared by using a similar conjugation protocol to that used in the case of 3a.
35. Although Jun-binding experiments with FOSIz 35aa can not be analyzed by using standard PAGE experiments, the relatively weak interaction of 3b can be considered as a valid control. Preliminary experiments of inhibition of binding of Jun to its consensus DNA sequence confirm that such a truncated peptide is a considerably weaker Jun-trapping agent than our dsDNA-peptide hybrid.
36. It has been shown that dimeric bZIP proteins can recognize half-site consensus sequences with relative high affinity; this suggests that one of their basic regions can interact with the phosphodiester surface of the DNA in a nonspecific manner: a) J. J. Hollenbeck, M. G. Oakley, Bio chemistry 2000, 39, 6380-6389;
37. b) I.-S. Chan; A. V. Fedorova, J. A. Shin, Biochemistry 2007, 46, 1663-1671.
38. A method to diagnose single-base-mismatched sequences that relies on the differences in the recognition properties of ss- and ds-DNA has recently been reported: P. C. Ray, Angew. Chem. 2006, 118, 1169-1172;
39. Angew. Chem. Int. Ed. 2006, 45, 1151-1154.
40. For recent examples on the use of nucleic acid hybridization to control the conformation and activity of proteins, see: a) B. Choi, G. Zocchi, J. Am. Chem. Soc. 2006, 128, 8541-8548;
41. b) L. Röglin, M. R. Ahmadian, O. Seitz, Angew. Chem. 2007, 119, 2759-2763;
42. Angew. Chem. Int. Ed. 2007, 46, 2704-2707.